Please login to the form below

Not currently logged in
Email:
Password:

Mylan hires Jacek Glinka as European head

He will join the firm from Poland’s Polpharma

Mylan Jacek GlinkaUS pharma company Mylan has named Jacek Glinka as president of its European business.

Glinka will join Mylan in December when he steps down from his role as CEO of Poland's Polpharma, which he headed up from 2003 to 2006 and then again from 2009 to the present.

During this time, he helped expand Polpharma from a small local biopharma to one that now stretches across Central and Eastern Europe and Asia. As a result of the expansion, including takeovers of firms in Poland and Kazakhstan, revenues doubled between 2011 and 2013 to reach more than $1bn.

In his role at Mylan, Glinka will oversee the company's growth plans in Europe and will report to chief operating officer Hal Korman.

“We believe Jacek's strong leadership, strategic thinking and operational discipline will build on the solid foundation and leadership team we already have in place, and maximise the many opportunities we see ahead for our European business,” said Mylan's CEO Heather Bresch.

Glinka added that he had been following Mylan for some time and he was confident that company could become a serious competitor in Europe.

“I look forward to leveraging my expertise, particularly in the exciting Central and Eastern European markets, to further expand Mylan's footprint,” he said.

21st October 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics